| detection of mechanical stimulus involved in sensory perception of sound | GO:0050910 | 16 | 0.998 | |
| detection of mechanical stimulus involved in sensory perception | GO:0050974 | 23 | 0.988 | |
| auditory receptor cell differentiation | GO:0042491 | 37 | 0.980 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.966 | |
| vestibular receptor cell development | GO:0060118 | 2 | 0.951 | |
| cardiac muscle tissue growth involved in heart morphogenesis | GO:0003245 | 1 | 0.933 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.932 | |
| ear development | GO:0043583 | 200 | 0.932 | |
| auditory receptor cell morphogenesis | GO:0002093 | 15 | 0.917 | |
| inner ear receptor cell development | GO:0060119 | 39 | 0.910 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.908 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.905 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.902 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.880 | |
| renal system process | GO:0003014 | 48 | 0.877 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.873 | |
| equilibrioception | GO:0050957 | 3 | 0.862 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.860 | |
| regulation of g protein activated inward rectifier potassium channel activity | GO:1900128 | 1 | 0.856 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.820 | |
| epidermis development | GO:0008544 | 187 | 0.807 | |
| pilomotor reflex | GO:0097195 | 3 | 0.785 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.783 | |
| detection of external stimulus | GO:0009581 | 61 | 0.734 | |
| sensory perception of sound | GO:0007605 | 97 | 0.723 | |
| chloride transmembrane transport | GO:1902476 | 24 | 0.704 | |
| transmembrane transport | GO:0055085 | 412 | 0.702 | |
| ascending thin limb development | GO:0072021 | 2 | 0.700 | |
| muscle tissue development | GO:0060537 | 308 | 0.695 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.694 | |
| ear morphogenesis | GO:0042471 | 118 | 0.675 | |
| skin development | GO:0043588 | 220 | 0.674 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.674 | |
| hair cell differentiation | GO:0035315 | 40 | 0.659 | |
| potassium ion transport | GO:0006813 | 52 | 0.659 | |
| retina homeostasis | GO:0001895 | 23 | 0.646 | |
| renal system development | GO:0072001 | 225 | 0.556 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.549 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.547 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.547 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.530 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.527 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.516 | |
| spermatogenesis | GO:0007283 | 284 | 0.511 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.502 | |
| potassium ion import | GO:0010107 | 1 | 0.497 | |
| loop of henle development | GO:0072070 | 10 | 0.487 | |
| nephron epithelium development | GO:0072009 | 92 | 0.480 | |
| sensory perception | GO:0007600 | 245 | 0.477 | |
| tissue homeostasis | GO:0001894 | 115 | 0.476 | |
| inorganic anion transmembrane transport | GO:0098661 | 29 | 0.470 | |
| sensory system development | GO:0048880 | 3 | 0.464 | |
| metanephric thick ascending limb development | GO:0072233 | 2 | 0.460 | |
| parallel actin filament bundle assembly | GO:0030046 | 2 | 0.456 | |
| cellular homeostasis | GO:0019725 | 240 | 0.455 | |
| neurohypophysis development | GO:0021985 | 2 | 0.450 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.447 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.442 | |
| auditory receptor cell development | GO:0060117 | 20 | 0.437 | |
| regulation of potassium ion transmembrane transporter activity | GO:1901016 | 7 | 0.431 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.420 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.414 | |
| positive regulation of dipeptide transmembrane transport | GO:2001150 | 2 | 0.412 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.407 | |
| sulfate transmembrane transport | GO:1902358 | 3 | 0.395 | |
| cation transport | GO:0006812 | 399 | 0.394 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.392 | |
| interleukin 5 secretion | GO:0072603 | 2 | 0.392 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.388 | |
| membrane hyperpolarization | GO:0060081 | 21 | 0.387 | |
| inorganic anion transport | GO:0015698 | 43 | 0.387 | |
| detection of stimulus | GO:0051606 | 84 | 0.386 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.375 | |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.375 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.366 | |
| lateral line system development | GO:0048925 | 1 | 0.364 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.360 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.358 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.348 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.347 | |
| anion transport | GO:0006820 | 177 | 0.344 | |
| neuron projection guidance | GO:0097485 | 141 | 0.336 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.336 | |
| organic anion transport | GO:0015711 | 137 | 0.334 | |
| detection of mechanical stimulus | GO:0050982 | 27 | 0.325 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.323 | |
| growth involved in heart morphogenesis | GO:0003241 | 4 | 0.318 | |
| inner ear receptor stereocilium organization | GO:0060122 | 23 | 0.313 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.291 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.286 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 26 | 0.272 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.271 | |
| regulation of secretion | GO:0051046 | 274 | 0.267 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.265 | |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 | 0.265 | |
| cation homeostasis | GO:0055080 | 212 | 0.261 | |
| cell fate specification | GO:0001708 | 72 | 0.253 | |
| metanephric ascending thin limb development | GO:0072218 | 2 | 0.246 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.245 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.239 | |
| positive regulation of potassium ion transmembrane transport | GO:1901381 | 3 | 0.238 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.235 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.235 | |
| neuromuscular process | GO:0050905 | 99 | 0.231 | |
| brain segmentation | GO:0035284 | 3 | 0.231 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.224 | |
| cellular response to fructose stimulus | GO:0071332 | 2 | 0.220 | |
| vestibular reflex | GO:0060005 | 4 | 0.209 | |
| intracellular ph elevation | GO:0051454 | 3 | 0.205 | |
| oligopeptide transmembrane transport | GO:0035672 | 4 | 0.203 | |
| sphingosine 1 phosphate signaling pathway | GO:0003376 | 3 | 0.203 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.201 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.194 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.193 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.193 | |
| mrna processing | GO:0006397 | 63 | 0.191 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.191 | |
| positive regulation of hormone metabolic process | GO:0032352 | 3 | 0.186 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.186 | |
| mannitol transport | GO:0015797 | 1 | 0.185 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.185 | |
| locomotory behavior | GO:0007626 | 195 | 0.184 | |
| positive regulation of thyroid hormone generation | GO:2000611 | 2 | 0.182 | |
| synaptic transmission | GO:0007268 | 329 | 0.179 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.178 | |
| nephron development | GO:0072006 | 109 | 0.177 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.176 | |
| l glutamate uptake involved in synaptic transmission | GO:0051935 | 3 | 0.175 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.163 | |
| actin filament organization | GO:0007015 | 113 | 0.158 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.158 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.157 | |
| excretion | GO:0007588 | 22 | 0.155 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.155 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.154 | |
| metanephric distal convoluted tubule development | GO:0072221 | 5 | 0.154 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.153 | |
| vestibulocochlear nerve development | GO:0021562 | 7 | 0.152 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.151 | |
| heart morphogenesis | GO:0003007 | 178 | 0.151 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.150 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.148 | |
| kidney development | GO:0001822 | 213 | 0.147 | |
| positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0072108 | 3 | 0.147 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.144 | |
| adult behavior | GO:0030534 | 135 | 0.143 | |
| positive regulation of digestive system process | GO:0060456 | 2 | 0.141 | |
| l amino acid transport | GO:0015807 | 32 | 0.140 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.139 | |
| glucose homeostasis | GO:0042593 | 128 | 0.138 | |
| gland development | GO:0048732 | 330 | 0.135 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.133 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.132 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.131 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.131 | |
| transepithelial chloride transport | GO:0030321 | 4 | 0.130 | |
| tissue remodeling | GO:0048771 | 102 | 0.129 | |
| inner cell mass cell fate commitment | GO:0001827 | 2 | 0.128 | |
| nephron tubule development | GO:0072080 | 84 | 0.128 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.128 | |
| thyroid hormone metabolic process | GO:0042403 | 16 | 0.125 | |
| regulation of oligopeptide transport | GO:0090088 | 2 | 0.125 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.123 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.122 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.119 | |
| ectodermal cell fate commitment | GO:0001712 | 1 | 0.117 | |
| intracellular protein transport | GO:0006886 | 204 | 0.117 | |
| sulfur compound transport | GO:0072348 | 9 | 0.116 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.114 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.113 | |
| hormone metabolic process | GO:0042445 | 86 | 0.112 | |
| hindbrain formation | GO:0021576 | 1 | 0.112 | |
| amine metabolic process | GO:0009308 | 45 | 0.112 | |
| organic acid transport | GO:0015849 | 101 | 0.111 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.109 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.109 | |
| regulation of heart growth | GO:0060420 | 31 | 0.108 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.108 | |
| immune effector process | GO:0002252 | 321 | 0.108 | |
| spermatid differentiation | GO:0048515 | 115 | 0.107 | |
| auditory receptor cell stereocilium organization | GO:0060088 | 12 | 0.104 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.104 | |
| hindbrain development | GO:0030902 | 128 | 0.103 | |
| detection of stimulus involved in sensory perception | GO:0050906 | 44 | 0.103 | |
| cgmp metabolic process | GO:0046068 | 20 | 0.103 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.102 | |
| regulation of inositol trisphosphate biosynthetic process | GO:0032960 | 3 | 0.100 | |
| visual perception | GO:0007601 | 52 | 0.099 | |
| neural crest cell development | GO:0014032 | 48 | 0.098 | |
| epithalamus development | GO:0021538 | 2 | 0.098 | |
| developmental maturation | GO:0021700 | 193 | 0.096 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.095 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.094 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.094 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.093 | |
| urogenital system development | GO:0001655 | 261 | 0.092 | |
| proprioception involved in equilibrioception | GO:0051355 | 1 | 0.092 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.091 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.089 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.089 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.089 | |
| renal capsule formation | GO:0072129 | 1 | 0.088 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.088 | |
| regulation of protein localization | GO:0032880 | 231 | 0.087 | |
| sodium ion transport | GO:0006814 | 73 | 0.086 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.085 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.084 | |
| inflammatory response | GO:0006954 | 244 | 0.084 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.084 | |
| regulation of cell size | GO:0008361 | 72 | 0.083 | |
| amino acid import into cell | GO:1902837 | 4 | 0.083 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.082 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.081 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.081 | |
| response to hyperoxia | GO:0055093 | 2 | 0.081 | |
| macula densa development | GO:0072024 | 1 | 0.080 | |
| chloride transport | GO:0006821 | 32 | 0.080 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.080 | |
| peptide hormone processing | GO:0016486 | 9 | 0.080 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.080 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.079 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.079 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.079 | |
| male gamete generation | GO:0048232 | 285 | 0.077 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.077 | |
| heart growth | GO:0060419 | 45 | 0.076 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.076 | |
| skin morphogenesis | GO:0043589 | 38 | 0.076 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.076 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.076 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.076 | |
| cellular response to camp | GO:0071320 | 11 | 0.075 | |
| regulation of thyroid hormone generation | GO:2000609 | 4 | 0.074 | |
| metanephric nephron tubule epithelial cell differentiation | GO:0072257 | 5 | 0.073 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.073 | |
| protein secretion | GO:0009306 | 111 | 0.072 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.071 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.071 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.071 | |
| positive regulation of transcription from rna polymerase ii promoter by glucose | GO:0000432 | 3 | 0.071 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.070 | |
| regulation of hormone metabolic process | GO:0032350 | 15 | 0.070 | |
| circulatory system process | GO:0003013 | 197 | 0.069 | |
| metanephric capsule specification | GO:0072267 | 1 | 0.069 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.069 | |
| regulation of cell fate specification | GO:0042659 | 10 | 0.069 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.069 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.068 | |
| rna processing | GO:0006396 | 105 | 0.068 | |
| female gonad development | GO:0008585 | 71 | 0.068 | |
| endocrine process | GO:0050886 | 39 | 0.068 | |
| gastric acid secretion | GO:0001696 | 6 | 0.067 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.067 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.067 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.066 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.066 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.065 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.063 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.063 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.063 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.063 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.063 | |
| neuron recognition | GO:0008038 | 25 | 0.062 | |
| multicellular organism growth | GO:0035264 | 161 | 0.061 | |
| cardiac muscle cell action potential involved in contraction | GO:0086002 | 6 | 0.059 | |
| protein maturation | GO:0051604 | 176 | 0.059 | |
| regulation of high voltage gated calcium channel activity | GO:1901841 | 2 | 0.058 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.057 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.057 | |
| regulation of potassium ion transmembrane transport | GO:1901379 | 11 | 0.057 | |
| bone remodeling | GO:0046849 | 53 | 0.056 | |
| fluid transport | GO:0042044 | 14 | 0.056 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 4 | 0.056 | |
| proprioception | GO:0019230 | 4 | 0.056 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.056 | |
| oxygen metabolic process | GO:0072592 | 4 | 0.056 | |
| organelle assembly | GO:0070925 | 177 | 0.055 | |
| body fluid secretion | GO:0007589 | 53 | 0.055 | |
| organ growth | GO:0035265 | 117 | 0.055 | |
| developmental cell growth | GO:0048588 | 84 | 0.055 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.055 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.055 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.055 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.054 | |
| bicarbonate transport | GO:0015701 | 7 | 0.054 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.053 | |
| positive regulation of dipeptide transport | GO:2000880 | 2 | 0.053 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.053 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.053 | |
| transdifferentiation | GO:0060290 | 1 | 0.052 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.052 | |
| bone resorption | GO:0045453 | 38 | 0.052 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.052 | |
| reflex | GO:0060004 | 22 | 0.051 | |
| dipeptide transport | GO:0042938 | 2 | 0.051 | |
| l glutamate import into cell | GO:1990123 | 3 | 0.051 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.051 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.050 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.050 | |
| feeding behavior | GO:0007631 | 62 | 0.049 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.049 | |
| regulation of atrial cardiac muscle cell membrane repolarization | GO:0060372 | 1 | 0.049 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.049 | |
| renal capsule specification | GO:0072130 | 1 | 0.049 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.048 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.048 | |
| axonogenesis | GO:0007409 | 274 | 0.048 | |
| regulation of system process | GO:0044057 | 200 | 0.048 | |
| ectoderm formation | GO:0001705 | 3 | 0.048 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.048 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.048 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.047 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.047 | |
| cell adhesion | GO:0007155 | 329 | 0.047 | |
| regulation of cell growth | GO:0001558 | 91 | 0.047 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.047 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.047 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.047 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.047 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.047 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.046 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.046 | |
| calcium ion dependent exocytosis | GO:0017156 | 35 | 0.046 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.046 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.046 | |
| midbrain hindbrain boundary morphogenesis | GO:0021555 | 4 | 0.045 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.045 | |
| submandibular salivary gland formation | GO:0060661 | 1 | 0.045 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.044 | |
| epithelial cell development | GO:0002064 | 159 | 0.044 | |
| angiogenesis | GO:0001525 | 201 | 0.044 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.044 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.043 | |
| ventricular compact myocardium morphogenesis | GO:0003223 | 2 | 0.043 | |
| phagosome maturation | GO:0090382 | 4 | 0.043 | |
| ph elevation | GO:0045852 | 3 | 0.042 | |
| positive regulation of transmembrane transport | GO:0034764 | 29 | 0.042 | |
| regulation of interleukin 13 secretion | GO:2000665 | 2 | 0.042 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.041 | |
| hydrogen ion transmembrane transport | GO:1902600 | 25 | 0.041 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.041 | |
| foramen ovale closure | GO:0035922 | 1 | 0.041 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.041 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.041 | |
| response to oxygen levels | GO:0070482 | 62 | 0.041 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.041 | |
| response to acid chemical | GO:0001101 | 111 | 0.041 | |
| endocytosis | GO:0006897 | 168 | 0.040 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.040 | |
| spermatid development | GO:0007286 | 108 | 0.040 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.040 | |
| carnitine transport | GO:0015879 | 3 | 0.040 | |
| oviduct development | GO:0060066 | 3 | 0.039 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.039 | |
| cardiac muscle cell action potential | GO:0086001 | 11 | 0.039 | |
| regulation of gastric acid secretion | GO:0060453 | 2 | 0.039 | |
| epidermal cell fate specification | GO:0009957 | 1 | 0.039 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.039 | |
| ovarian follicle development | GO:0001541 | 40 | 0.039 | |
| rna splicing | GO:0008380 | 54 | 0.039 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.039 | |
| renal capsule development | GO:0072127 | 1 | 0.038 | |
| semicircular canal formation | GO:0060876 | 1 | 0.038 | |
| detection of mechanical stimulus involved in equilibrioception | GO:0050973 | 2 | 0.038 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.038 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.038 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.038 | |
| sensory organ boundary specification | GO:0008052 | 1 | 0.038 | |
| mrna metabolic process | GO:0016071 | 84 | 0.038 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.038 | |
| salivary gland development | GO:0007431 | 37 | 0.038 | |
| dicarboxylic acid transport | GO:0006835 | 29 | 0.038 | |
| semicircular canal fusion | GO:0060879 | 1 | 0.037 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.037 | |
| dendrite development | GO:0016358 | 115 | 0.037 | |
| granulosa cell differentiation | GO:0060014 | 1 | 0.037 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.037 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.037 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.037 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.037 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.036 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.036 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.036 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.036 | |
| mesangial cell development | GO:0072143 | 4 | 0.036 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.036 | |
| metanephric tubule development | GO:0072170 | 18 | 0.035 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.035 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 28 | 0.035 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.035 | |
| dct cell differentiation | GO:0072069 | 3 | 0.035 | |
| blood coagulation | GO:0007596 | 76 | 0.035 | |
| regulation of ph | GO:0006885 | 26 | 0.034 | |
| response to retinoic acid | GO:0032526 | 56 | 0.034 | |
| renal vesicle induction | GO:0072034 | 3 | 0.034 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.034 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.034 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.034 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.034 | |
| amino acid uptake involved in synaptic transmission | GO:0051933 | 3 | 0.033 | |
| bronchiole development | GO:0060435 | 3 | 0.033 | |
| dephosphorylation | GO:0016311 | 129 | 0.033 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.033 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.033 | |
| exocrine system development | GO:0035272 | 45 | 0.033 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.033 | |
| mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:1901145 | 4 | 0.033 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.033 | |
| regulation of cell motility | GO:2000145 | 236 | 0.033 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.033 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.033 | |
| regulation of t helper 2 cell cytokine production | GO:2000551 | 3 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 7 | 0.032 | |
| urate transport | GO:0015747 | 1 | 0.032 | |
| regulation of vascular wound healing | GO:0061043 | 2 | 0.032 | |
| action potential | GO:0001508 | 78 | 0.032 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.032 | |
| defecation | GO:0030421 | 1 | 0.032 | |
| regulation of action potential | GO:0098900 | 4 | 0.031 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.031 | |
| cilium assembly | GO:0042384 | 81 | 0.031 | |
| cytokine production | GO:0001816 | 319 | 0.031 | |
| response to inorganic substance | GO:0010035 | 96 | 0.031 | |
| histamine uptake | GO:0051615 | 1 | 0.031 | |
| metanephric capsule formation | GO:0072266 | 1 | 0.031 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.031 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.031 | |
| cardiac chamber development | GO:0003205 | 108 | 0.031 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.031 | |
| kidney epithelium development | GO:0072073 | 121 | 0.030 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.030 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.030 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.030 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.030 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.030 | |
| hypothalamus cell differentiation | GO:0021979 | 8 | 0.030 | |
| establishment or maintenance of neuroblast polarity | GO:0045196 | 1 | 0.030 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.030 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.030 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.030 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.029 | |
| rhombomere 3 morphogenesis | GO:0021658 | 2 | 0.029 | |
| response to purine containing compound | GO:0014074 | 28 | 0.029 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.029 | |
| detection of monosaccharide stimulus | GO:0034287 | 1 | 0.029 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.029 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.029 | |
| response to oxidative stress | GO:0006979 | 123 | 0.029 | |
| mapk cascade | GO:0000165 | 281 | 0.029 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.029 | |
| regulation of dipeptide transmembrane transport | GO:2001148 | 2 | 0.029 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.029 | |
| oxidation reduction process | GO:0055114 | 342 | 0.029 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.029 | |
| adenohypophysis development | GO:0021984 | 14 | 0.029 | |
| peptide transport | GO:0015833 | 133 | 0.029 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.029 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.029 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.028 | |
| immunoglobulin secretion involved in immune response | GO:0002380 | 2 | 0.028 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.028 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.028 | |
| b cell activation | GO:0042113 | 161 | 0.028 | |
| stem cell differentiation | GO:0048863 | 268 | 0.028 | |
| semicircular canal morphogenesis | GO:0048752 | 7 | 0.028 | |
| negative regulation of transcription by glucose | GO:0045014 | 1 | 0.028 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.028 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.028 | |
| eye photoreceptor cell fate commitment | GO:0042706 | 2 | 0.027 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.027 | |
| respiratory system development | GO:0060541 | 190 | 0.027 | |
| cell fate commitment | GO:0045165 | 210 | 0.027 | |
| positive regulation of inositol trisphosphate biosynthetic process | GO:0032962 | 2 | 0.027 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.027 | |
| renal tubule development | GO:0061326 | 87 | 0.027 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.027 | |
| positive regulation of cell migration involved in sprouting angiogenesis | GO:0090050 | 3 | 0.027 | |
| striated muscle contraction | GO:0006941 | 45 | 0.027 | |
| response to fructose | GO:0009750 | 2 | 0.027 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.026 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.026 | |
